DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients. - sprookjes - yvandenbroek - TriplyDB

DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients.

DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients.

http://www.wikidata.org/entity/Q38097536

about

Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.Pharmacogenetics of cancer therapy: breakthroughs from beyond?Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells.Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells.DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1.Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients.Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma (-)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer.Survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage and apoptosis in Bcl-xL silenced glioma cell lines.Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.

P2860

Q34227615-9A92FE22-B20C-43DC-88EA-E7E153C10592 Q38776883-74D4C474-CE2D-4441-87B4-51F7FFB3D4CD Q38788948-D6766B4B-9526-42D0-B6F1-5235E6A9B5D8 Q38873958-C9ACEFAD-2479-4A60-8B31-AFCE8813FCC2 Q40401994-97C4F085-ED88-48A7-8D67-DBD03CF48852 Q40691174-F8E2D413-C676-4C1C-B46E-F582D727D525 Q41002840-608CBF87-DAD2-42C0-B573-B17544094614 Q42321598-73678683-313E-4C51-8BB2-704B8458B23A Q48445482-5EC8B6B2-82FC-472A-AC3B-944E829BF94F Q51504437-16F74665-C4C7-4CBC-B52A-3825F3DE4979

P2860

DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients.

http://www.wikidata.org/entity/Q38097536

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

DNA repair and cytotoxic drugs ...... all-cell lung cancer patients.

@en

type

label

DNA repair and cytotoxic drugs ...... all-cell lung cancer patients.

@en

prefLabel

DNA repair and cytotoxic drugs ...... all-cell lung cancer patients.

@en

P1433

Q38097536-C1A9B34B-1B61-49BA-95C1-8CA7E22FDC51

P1476

Q38097536-26EF9FC0-A229-4294-A85E-F2E53899C775

P2093

Q38097536-7B5C8F28-0639-4A3C-8291-EBEE4FC6F913

P2860

Q38097536-0035EF4C-5121-4A88-B8EC-19853F07A7EB

Q38097536-00EADEB3-5EAA-455F-A7CD-2EE0FB73C3FB

Q38097536-03E92C3F-33F7-4AD4-8B8F-EE2EEB6BB307

Q38097536-0424B31A-F33B-4B32-8929-670D12846D02

Q38097536-06295BAA-295B-4964-A564-37D31746F484

Q38097536-06BE4718-53E1-480E-8703-0016167CE0D9

Q38097536-077AB34B-D6AB-445F-AF4C-D35A696A99A1

Q38097536-0A4B3E8B-1F69-4855-93A7-5E1D4C51A4BE

Q38097536-0B3A6E0E-FF9D-408A-9628-E5A556E1BBE6

Q38097536-0EEC6200-C3FD-4B78-9B93-29F51F8ED8EE

P304

Q38097536-B65734F8-4D4B-4A90-A493-95F4E76CCC1C

P31

Q38097536-E46E98EB-CD1C-47B9-A3ED-D14FD4A7CDCB

P356

Q38097536-3AF94518-7F1F-42ED-B69B-4CD2E03A4101

P433

Q38097536-0E83115B-8FBC-4BB6-95AA-C6002AB23705

P478

Q38097536-44539C56-3E30-42D4-A619-6A09BC0C6F26

P50

Q38097536-7A928D4F-6CB5-4665-BF0A-05598064A482

Q38097536-A7E7676D-C592-4A57-AE63-4D5F5CFF369B

Q38097536-C095DBD1-AEF4-4780-8BAC-114ABC7BCDF9

P577

Q38097536-313F4E65-A884-4F76-95DD-E0FD4F8EB512

P5875

Q38097536-701C865F-71C9-4BE3-A38B-99DFE8E58FB6

P698

Q38097536-925A3E7D-3CAB-45F5-9248-A1C133BE6401

P356

P1433

Pharmacogenomics

P1476

DNA repair and cytotoxic drugs ...... mall-cell lung cancer patients

@en

P2093

Joana Assis

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Genome maintenance mechanisms for preventing cancer

DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma

Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl

Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells

DNA double-strand breaks: signaling, repair and the cancer connection

P304

689-700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.13.48

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Raquel Catarino

Augusto Nogueira

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236186869

http://www.w3.org/2001/XMLSchema#string

P698

23570471

http://www.w3.org/2001/XMLSchema#string